Senator Mike Braun @SenatorBraun
Disappointed to see @US_FDA’s vote against Amylyx's ALS drug. We need my Promising Pathway Act to provide the regulatory framework necessary for rare disease drug development and expediting beneficial outcomes for patients. The ALS community does not have time to lose. — PolitiTweet.org
